|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: CYTOGEN CORP, 10-Q, EX-10.2, 2000-11-14 |
Next: MEDICAL RESOURCES INC /DE/, 10-Q, 2000-11-14 |
<TABLE> <S> <C>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
CONSOLIDATED BALANCE SHEETS AS OF SEPTEMBER 30, 2000 AND THE CONSOLIDATED
STATEMENTS OF OPERATIONS FOR THE NINE-MONTH PERIOD ENDED SEPTEMBER 30, 2000 AND
IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<S> <C>
<PERIOD-TYPE> 9-MOS
<FISCAL-YEAR-END> DEC-31-2000
<PERIOD-START> JAN-01-2000
<PERIOD-END> SEP-30-2000
<CASH> 14,178,000
<SECURITIES> 0
<RECEIVABLES> 2,449,000
<ALLOWANCES> (64,000)
<INVENTORY> 631,000
<CURRENT-ASSETS> 410,000
<PP&E> 8,375,000
<DEPRECIATION> (6,342,000)
<TOTAL-ASSETS> 20,696,000
<CURRENT-LIABILITIES> 5,011,000
<BONDS> 0
0
0
<COMMON> 756,000
<OTHER-SE> 976,523,000
<TOTAL-LIABILITY-AND-EQUITY> 20,696,000
<SALES> 5,473,000
<TOTAL-REVENUES> 7,167,000
<CGS> 3,047,000
<TOTAL-COSTS> 6,742,000
<OTHER-EXPENSES> 22,048,000
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 133,000
<INCOME-PRETAX> (21,211,000)
<INCOME-TAX> 0
<INCOME-CONTINUING> (21,211,000)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (21,211,000)
<EPS-BASIC> (0.29)
<EPS-DILUTED> (0.29)
</TABLE>
|
|